Connect with us

Company News

Cadila Healthcare Ltd Receives Zero Observation From USFDA For Baddi Facility

The USFDA inspected Cadila Healthcare Ltd’s formulations manufacturing facility located at Baddi from 2nd to 9th March, 2020. This was a cGMP and Post Approval Inspection. At the end of the inspection, no observation (483) is issued.

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.265.6 as compared to the previous close of Rs. 263.55. The total number of shares traded during the day was 57284 in over 1329 trades.

The stock hit an intraday high of Rs. 268.45 and intraday low of 255.5. The net turnover during the day was Rs. 15147962.-Equity Bulls

Copyright © 2024 Medical Buyer

error: Content is protected !!